Specific primers were designed to amplify 170–200 bp fragments in MGMT’s exon 1 and exon 2 in the three GBM cell lines; the DNA products obtained after routine RT-PCR and their relative expression are shown in Figure 4A,B, respectively. The gene discussed is MGMT; the disease is glioblastoma.